Notable Downgrades: BioMarin Pharmaceutical (BMRN), Finisar (FNSR), Oracle (ORCL), Zoe’s Kitchen (ZOES)

Analysts at Robert W. Baird are out with a report today downgrading shares of BioMarin Pharmaceutical Inc. (BMRN) with a ‘Neutral‘ from ‘Outperform‘ rating. The firm however, raised its price target for the company to $133 from $125. BMRN shares recently lost $1.21 to $137.45. In the past 52 weeks, shares of San Rafael, California-based […] View the full post at: Notable Downgrades: BioMarin Pharmaceutical (BMRN), Finisar (FNSR), Oracle (ORCL), Zoe’s Kitchen (ZOES) Related posts: Oracle (ORCL) Looks Downright Visionary Oracle (ORCL): Finally Bitten Off More than it Can Chew? Oracle Makes New Post Tech-Bubble Highs